[Targeted therapy with imatinib has reformed the treatment of chronic myeloid leukemia]
- PMID: 12812107
[Targeted therapy with imatinib has reformed the treatment of chronic myeloid leukemia]
Similar articles
-
Imatinib mesylate therapy in chronic myeloid leukaemia: the floodgates opened.J Assoc Physicians India. 2007 Feb;55:99-100. J Assoc Physicians India. 2007. PMID: 17571737 No abstract available.
-
Trisomy 8 finding treatment of imatinib mesylate in chronic myeloid leukemia cases.Exp Hematol. 2005 Feb;33(2):151. doi: 10.1016/j.exphem.2004.10.015. Exp Hematol. 2005. PMID: 15676207 No abstract available.
-
Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Commentary re: A. N. Mohamed et al., The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin. Cancer Res., 9: 1333-1337, 2003.Clin Cancer Res. 2003 Apr;9(4):1248-52. Clin Cancer Res. 2003. PMID: 12684391 Review. No abstract available.
-
Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory.Am J Hematol. 2004 Feb;75(2):92-5. doi: 10.1002/ajh.10456. Am J Hematol. 2004. PMID: 14755375
-
Important therapeutic targets in chronic myelogenous leukemia.Clin Cancer Res. 2007 Feb 15;13(4):1089-97. doi: 10.1158/1078-0432.CCR-06-2147. Clin Cancer Res. 2007. PMID: 17317816 Review.
MeSH terms
Substances
LinkOut - more resources
Medical